MCARH109

· Memorial Sloan Kettering Cancer Center

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for MCARH109, covering 2025-07-09 to 2025-09-22. Get the full timeline:

Most recent: Clinical Trial Update: MCARH109 Chimeric Antigen Receptor (CAR) Modified T Cells for the Treatment of Multiple Myeloma [Phase 1]